Dr Arshad Khanani shares insights, including data on anti-VEGF treatment and macular atrophy, fibrosis biomarkers, and PCV combination therapies.

A preliminary study showed first evidence of normalization of T3, T4, within weeks, with additional thyroid eye disease effects.

With growing evidence that loneliness increases the risk for multiple diseases, there are questions about the mechanisms at ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Cannabis use may lead to thinning of the cerebral cortex in adolescents, research in mice and humans suggested. The ...

Europe is grappling with general neurology workforce shortages that could have serious consequences for patient care. The ...

A fasting-mimicking diet (FMD) restored kidney function in a rodent model and promoted renoprotection in patients with ...

PHILADELPHIA — New research challenges the traditional practice of continuing vasoconstrictor therapy for 5 days after ...

Federal lawmakers are rushing to soften the blow of Medicare’s 2025 effective pay cut for doctors in 2025, introducing a bill ...

CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has ...

SAVANNAH, Ga. — When Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, pediatric neurologist Nancy L. Kuntz, MD, ...

Patients with cancer who participated in the Medicare Low-Income Subsidy program were less likely to receive any systemic ...